A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)
Public ClinicalTrials.gov record NCT01716806. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial will study brentuximab vedotin to find out whether it is an effective treatment for Hodgkin lymphoma (HL) and peripheral T-cell lymphoma (PTCL). Participants in this study will be older or will have other conditions that make them unable to have standard chemotherapy treatment. The study will look at brentuximab vedotin alone and combined with other drugs.
Study identification
- NCT ID
- NCT01716806
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 131 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2012 (Actual)
- Primary completion
- Apr 7, 2023 (Actual)
- Completion
- Sep 12, 2023 (Actual)
- Last update posted
- Jun 11, 2024
2012 – 2023
United States locations
- U.S. sites
- 49
- U.S. states
- 23
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35249 | — |
| University of South Alabama - Mitchell Cancer Institute | Mobile | Alabama | 36604 | — |
| Alaska Urological Institute | Anchorage | Alaska | 99503 | — |
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| Arizona Oncology Associates, PC - HOPE | Tucson | Arizona | 85710 | — |
| Arizona Cancer Center / University of Arizona | Tucson | Arizona | 85724-5024 | — |
| Highlands Oncology Group | Springdale | Arkansas | J. Thaddeus Beck | — |
| Providence St Joseph Medical Center | Burbank | California | 91505 | — |
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| Wilshire Oncology Medical Group Inc. | Pomona | California | 91767 | — |
| Rocky Mountain Cancer Centers - Aurora | Aurora | Colorado | 80012 | — |
| Florida Cancer Affiliates | Trinity | Florida | 34655 | — |
| IACT Health | Columbus | Georgia | 31904 | — |
| Georgia Cancer Specialists / Northside Hospital Cancer Institute | Sandy Springs | Georgia | 30341 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Illinois Cancer Specialists / Advocate Lutheran General Hospital | Niles | Illinois | 60714 | — |
| American Oncology Networks LLC | Bethesda | Maryland | 20817 | — |
| Karmanos Cancer Institute / Wayne State University | Detroit | Michigan | 48201 | — |
| Minnesota Oncology Hematology P.A. | Minneapolis | Minnesota | 55404 | — |
| Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | — |
| Morristown Medical Center/ Carol G. Simon Cancer Center | Morristown | New Jersey | 07960 | — |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | — |
| New York Oncology Hematology, P.C. | Albany | New York | 12208 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| James P. Wilmot Cancer Center / University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Oncology Hematology Care | Cincinnati | Ohio | 45242 | — |
| James Cancer Hospital / Ohio State University | Columbus | Ohio | 43210 | — |
| Willamette Valley Cancer Institute and Research Center | Eugene | Oregon | 97401 | — |
| Northwest Cancer Specialists, P.C. | Tigard | Oregon | 97223 | — |
| Prisma Health | Greenville | South Carolina | 29615 | — |
| Arlington Cancer Center | Arlington | Texas | 76012 | — |
| Texas Oncology - Bedford | Bedford | Texas | 76022 | — |
| Texas Oncology - Presbyterian Cancer Center Dallas | Dallas | Texas | 75231 | — |
| Texas Oncology - Denton South | Denton | Texas | Kurkul | — |
| Texas Oncology - Fort Worth 12th Avenue | Fort Worth | Texas | 76104 | — |
| Houston Methodist Cancer Center | Houston | Texas | 77030 | — |
| MD Anderson Cancer Center / University of Texas | Houston | Texas | 77030 | — |
| Texas Oncology - Longview | Longview | Texas | 75601 | — |
| Texas Oncology - McAllen | McAllen | Texas | 78503 | — |
| Texas Oncology - Seton Williamson | Round Rock | Texas | 78665 | — |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | — |
| Virginia Commonwealth University Medical Center | Richmond | Virginia | 23298 | — |
| Oncology and Hematology Assoc of SW VA DBA Blue Ridge Cancer Care | Salem | Virginia | 24153 | — |
| Shenandoah Oncology P.C. | Winchester | Virginia | 22601 | — |
| Benaroya Research Institute/Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
| Wenatchee Valley Medical Center | Wenatchee | Washington | 98821 | — |
| Carbone Cancer Center / University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01716806, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 11, 2024 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01716806 live on ClinicalTrials.gov.